280 related articles for article (PubMed ID: 28232146)
1. Effects of klotho deletion from bone during chronic kidney disease.
Kaludjerovic J; Komaba H; Lanske B
Bone; 2017 Jul; 100():50-55. PubMed ID: 28232146
[TBL] [Abstract][Full Text] [Related]
2. Role of Klotho in bone and implication for CKD.
Komaba H; Lanske B
Curr Opin Nephrol Hypertens; 2018 Jul; 27(4):298-304. PubMed ID: 29697410
[TBL] [Abstract][Full Text] [Related]
3. Klotho/FGF23 and Wnt Signaling as Important Players in the Comorbidities Associated with Chronic Kidney Disease.
Muñoz-Castañeda JR; Rodelo-Haad C; Pendon-Ruiz de Mier MV; Martin-Malo A; Santamaria R; Rodriguez M
Toxins (Basel); 2020 Mar; 12(3):. PubMed ID: 32188018
[TBL] [Abstract][Full Text] [Related]
4. Klotho expression in long bones regulates FGF23 production during renal failure.
Kaludjerovic J; Komaba H; Sato T; Erben RG; Baron R; Olauson H; Larsson TE; Lanske B
FASEB J; 2017 May; 31(5):2050-2064. PubMed ID: 28183805
[TBL] [Abstract][Full Text] [Related]
5. Fgf23 and parathyroid hormone signaling interact in kidney and bone.
Andrukhova O; Streicher C; Zeitz U; Erben RG
Mol Cell Endocrinol; 2016 Nov; 436():224-39. PubMed ID: 27498418
[TBL] [Abstract][Full Text] [Related]
6. Targeted deletion of Klotho in kidney distal tubule disrupts mineral metabolism.
Olauson H; Lindberg K; Amin R; Jia T; Wernerson A; Andersson G; Larsson TE
J Am Soc Nephrol; 2012 Oct; 23(10):1641-51. PubMed ID: 22878961
[TBL] [Abstract][Full Text] [Related]
7. FGF23 Regulates Bone Mineralization in a 1,25(OH)2 D3 and Klotho-Independent Manner.
Murali SK; Roschger P; Zeitz U; Klaushofer K; Andrukhova O; Erben RG
J Bone Miner Res; 2016 Jan; 31(1):129-42. PubMed ID: 26235988
[TBL] [Abstract][Full Text] [Related]
8. Update on FGF23 and Klotho signaling.
Erben RG
Mol Cell Endocrinol; 2016 Sep; 432():56-65. PubMed ID: 27178987
[TBL] [Abstract][Full Text] [Related]
9. FGF23 beyond Phosphotropic Hormone.
Takashi Y; Fukumoto S
Trends Endocrinol Metab; 2018 Nov; 29(11):755-767. PubMed ID: 30217676
[TBL] [Abstract][Full Text] [Related]
10. The role of vitamin D in the FGF23, klotho, and phosphate bone-kidney endocrine axis.
Haussler MR; Whitfield GK; Kaneko I; Forster R; Saini R; Hsieh JC; Haussler CA; Jurutka PW
Rev Endocr Metab Disord; 2012 Mar; 13(1):57-69. PubMed ID: 21932165
[TBL] [Abstract][Full Text] [Related]
11. Klotho expression in osteocytes regulates bone metabolism and controls bone formation.
Komaba H; Kaludjerovic J; Hu DZ; Nagano K; Amano K; Ide N; Sato T; Densmore MJ; Hanai JI; Olauson H; Bellido T; Larsson TE; Baron R; Lanske B
Kidney Int; 2017 Sep; 92(3):599-611. PubMed ID: 28396120
[TBL] [Abstract][Full Text] [Related]
12. FGF23 expression is stimulated in transgenic α-Klotho longevity mouse model.
Xiao Z; King G; Mancarella S; Munkhsaikhan U; Cao L; Cai C; Quarles LD
JCI Insight; 2019 Dec; 4(23):. PubMed ID: 31801907
[TBL] [Abstract][Full Text] [Related]
13. [FGF23 and osteonetwork].
Fukumoto S
Clin Calcium; 2016 Aug; 26(8):1143-7. PubMed ID: 27461497
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor 23, klotho and heparin.
Thomas SM; Li Q; Faul C
Curr Opin Nephrol Hypertens; 2023 Jul; 32(4):313-323. PubMed ID: 37195242
[TBL] [Abstract][Full Text] [Related]
15. [Role of parathyroid hormone in Klotho-FGF23 system].
Kimura T; Shiizaki K; Kuro-O M
Clin Calcium; 2016 Jun; 26(6):859-66. PubMed ID: 27230841
[TBL] [Abstract][Full Text] [Related]
16. FGF23-Klotho signaling axis in the kidney.
Erben RG; Andrukhova O
Bone; 2017 Jul; 100():62-68. PubMed ID: 27622885
[TBL] [Abstract][Full Text] [Related]
17. [Updates on rickets and osteomalacia: various roles of Klotho and FGF23 in vivo ].
Imura A
Clin Calcium; 2013 Oct; 23(10):1476-82. PubMed ID: 24076646
[TBL] [Abstract][Full Text] [Related]
18. Klotho/FGF23 Axis in CKD.
Tsuchiya K; Nagano N; Nitta K
Contrib Nephrol; 2015; 185():56-65. PubMed ID: 26023015
[TBL] [Abstract][Full Text] [Related]
19. Pleiotropic Actions of FGF23.
Erben RG
Toxicol Pathol; 2017 Oct; 45(7):904-910. PubMed ID: 29096595
[TBL] [Abstract][Full Text] [Related]
20. Nuclear isoforms of fibroblast growth factor 2 are novel inducers of hypophosphatemia via modulation of FGF23 and KLOTHO.
Xiao L; Naganawa T; Lorenzo J; Carpenter TO; Coffin JD; Hurley MM
J Biol Chem; 2010 Jan; 285(4):2834-46. PubMed ID: 19933269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
